2008
DOI: 10.1242/jcs.022566
|View full text |Cite
|
Sign up to set email alerts
|

PLD regulates myoblast differentiation through the mTOR-IGF2 pathway

Abstract: investigation has revealed that PLD1 is unlikely to regulate myogenesis through modulation of the actin cytoskeleton as previously suggested. Instead, PLD1 positively regulates mTOR signaling leading to the production of IGF2, an autocrine factor instrumental for the initiation of satellite cell differentiation. Furthermore, exogenous IGF2 fully rescues the differentiation defect resulting from PLD1 knockdown. Hence, PLD1 is critically involved in skeletal myogenesis by regulating the mTOR-IGF2 pathway. Key wo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
68
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 63 publications
(75 citation statements)
references
References 47 publications
7
68
0
Order By: Relevance
“…The reported plasma membrane localization of PLD2, 69,71 seems to disagree with such a role. Indeed, our knockdown studies in both HEK293 cells 35 and C2C12 myoblasts 72 suggest that PLD2 is dispensable for mTORC1 activation. However, the presence of PLD2 in the cytoplasm, albeit not a major fraction, cannot be ruled out.…”
Section: Pld1 or Pld2?mentioning
confidence: 90%
See 1 more Smart Citation
“…The reported plasma membrane localization of PLD2, 69,71 seems to disagree with such a role. Indeed, our knockdown studies in both HEK293 cells 35 and C2C12 myoblasts 72 suggest that PLD2 is dispensable for mTORC1 activation. However, the presence of PLD2 in the cytoplasm, albeit not a major fraction, cannot be ruled out.…”
Section: Pld1 or Pld2?mentioning
confidence: 90%
“…26 A PLD1-mTOR pathway is also found to be required for skeletal myoblast differentiation by regulating the expression of insulin-like growth factor II. 72 Furthermore, mTOR activation in Syk-dependent survival of follicular lymphoma cells, 82 lacritin regulation of restricted epithelial proliferation, 83 melanogenesis of mouse B16 melanoma cells, 84 and collagen type I production in human dermal fibroblasts 85 all involve PLD and PA.…”
Section: The Pld-mtor Connection: An Asset For Mammalsmentioning
confidence: 99%
“…Lentivirus packaging and testing were performed as previously described (24). The Sigma clone ID for the shRNA constructs used in this study are: mTOR #1, NM_020009.1-7569s1c1; mTOR #2, NM_020009.1-5493s1c1; rictor #1, NM_030168.2-6240s1c1, rictor #2, NM_030168.2-5030s1c1; Rheb #1, NM_053075 .2-740s1c1, Rheb #2, NM_053075.2-339s1c1; IRS1 #1, NM_010570.4 -2308s21c1, IRS1 #2, NM_010570.2-3585s1c1; S6K1 #1, NM_028259.1-264s1c1; S6K1 #2, NM_028259.1-616s1c1; raptor #1, NM_028898.1-3729s1c1.…”
Section: Methodsmentioning
confidence: 99%
“…Clone IDs are: Flt3L #1, TRCN0000025059; Flt3L #2, TRCN0000025060; Flt3 #1, TRCN0000023739; Flt3 #2, TRCN0000378645; p120RasGAP, TRCN0000322311; Erk1, TRCN0000234920; Erk2, TRCN0000360489. Lentivirus packaging was performed as previously described (Yoon and Chen, 2008). Virally transduced C2C12 cells were selected in 3 mg/ml puromycin for 2 days, followed by differentiation for 3 days.…”
Section: Lentivirus-mediated Rnaimentioning
confidence: 99%